Teg6s Hemostasis System
Payments companies reported to CMS as associated with Teg6s Hemostasis System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Teg6s Hemostasis System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Teg6s Hemostasis System
These are the largest totals companies reported as associated with Teg6s Hemostasis System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Cho | Baltimore, MD | Anesthesiology | $49,165.38 |
| Keshav Deshpande | Columbus, OH | Trauma Surgery | $35,987.40 |
| Roman Dudaryk | Miami, FL | Anesthesiology | $35,743.58 |
| Courtney Maxey Jones | Johnson City, NY | Anesthesiology | $27,934.39 |
| Daniel Berson | Austin, TX | Anesthesiology | $24,610.49 |
| Michael Moront | Toledo, OH | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $24,408.97 |
| Steven Frank | Towson, MD | Anesthesiology | $22,972.94 |
| Babak Sarani | Washington, DC | Surgery | $12,582.89 |
| Evan Pivalizza | Houston, TX | Anesthesiology | $12,507.98 |
| Bryan Cotton | Nashville, TN | Trauma Surgery | $10,333.71 |
Prescribed Teg6s Hemostasis System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.